Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in Can Respir J

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    January 2022
  1. OZYURT S, Ozcelik N, Kara BY, Arpa M, et al
    Evaluation of Thiol/Disulfide Homeostasis in Bronchiectasis.
    Can Respir J. 2022;2022:8340450.
    PubMed     Abstract available


  2. LEE JU, Jeong JY, Kim MK, Min SA, et al
    Association of GSTM1 and GSTT1 Null Genotypes with Toluene Diisocyanate-Induced Asthma.
    Can Respir J. 2022;2022:7977937.
    PubMed     Abstract available


  3. ZHANG K, Zou X, Ma Z, Liu X, et al
    Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis.
    Can Respir J. 2022;2022:8175508.
    PubMed     Abstract available


  4. CAI CS, Wang J
    Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients.
    Can Respir J. 2022;2022:8369521.
    PubMed     Abstract available


  5. MOU S, Zhang W, Deng Y, Tang Z, et al
    Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients.
    Can Respir J. 2022;2022:7609083.
    PubMed     Abstract available


  6. IZHAKIAN S, Harper E, Gorelik O, Frajman A, et al
    Carboxyhemoglobin Does Not Predict the Need of Mechanical Ventilation and Prognosis during COPD Exacerbation.
    Can Respir J. 2022;2022:6689805.
    PubMed     Abstract available


  7. LIU H, Li Y, Zhang X, Shi M, et al
    Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
    Can Respir J. 2022;2022:8509396.
    PubMed     Abstract available


  8. ZENG Z, Liu Q, Huang X, Lu C, et al
    Prognostic Role of Chronic Obstructive Pulmonary Disease and Asthma Physiology Score for in-Hospital and 1-year Mortality in Patients with Acute Exacerbations of COPD.
    Can Respir J. 2022;2022:4110562.
    PubMed     Abstract available


  9. LIU C, Ran R, Li X, Liu G, et al
    Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.
    Can Respir J. 2022;2022:3982335.
    PubMed     Abstract available


  10. QIU Y, Wang Y, Shen N, Wang Q, et al
    Nomograms for Predicting Coexisting Cardiovascular Disease and Prognosis in Chronic Obstructive Pulmonary Disease: A Study Based on NHANES Data.
    Can Respir J. 2022;2022:5618376.
    PubMed     Abstract available


  11. ZHAO S, Zheng L, Zhu M, Shui Y, et al
    Intensive Intervention Improves Outcomes for Chronic Obstructive Pulmonary Disease Patients: A Medical Consortium-Based Management.
    Can Respir J. 2022;2022:6748330.
    PubMed     Abstract available


  12. DING Q, Mi BB, Wei X, Li J, et al
    Small Airway Dysfunction in Chronic Bronchitis with Preserved Pulmonary Function.
    Can Respir J. 2022;2022:4201786.
    PubMed     Abstract available


  13. GONG Y, Lin C, Jin Y, Chen R, et al
    The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2022;2022:2878648.
    PubMed     Abstract available


  14. SUN D, Lin R, Ouyang Y
    The Role of CD40, CD86, and Glutathione S-Transferase Omega 1 in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2022;2022:6810745.
    PubMed     Abstract available


  15. YAN F, Hu X, He L, Jiao K, et al
    ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway.
    Can Respir J. 2022;2022:8437348.
    PubMed     Abstract available


  16. DORSCHEID DR, Lee JK, Ramesh W, Greenwald M, et al
    Guidance for Administering Biologics for Severe Asthma and Allergic Conditions.
    Can Respir J. 2022;2022:9355606.
    PubMed     Abstract available


    January 2021
  17. XU W, Zhao R, Yuan B
    The Therapeutic Effect of Traditional LiuJunZi Decoction on Ovalbumin-Induced Asthma in Balb/C Mice.
    Can Respir J. 2021;2021:6406295.
    PubMed     Abstract available


  18. DING Q, Wei X, Li J, Gao YZ, et al
    Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:9996305.
    PubMed     Abstract available


  19. BEUTE J, Boermans P, KleinJan A
    Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.
    Can Respir J. 2021;2021:7456208.
    PubMed     Abstract available


  20. CHU S, Ma L, Wei J, Wang J, et al
    Smoking Status Modifies the Relationship between Th2 Biomarkers and Small Airway Obstruction in Asthma.
    Can Respir J. 2021;2021:1918518.
    PubMed     Abstract available


  21. SIDLETSKAYA KA, Vitkina TI, Denisenko YK, Mineeva EE, et al
    Role of Toll-Like Receptor 2 in Regulation of T-Helper Immune Response in Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:5596095.
    PubMed     Abstract available


  22. JU Y, Ma X, Li H, Liu S, et al
    Relationship between Air Pollution and Hospital Admissions for Chronic Obstructive Pulmonary Disease in Changchun, China: A Season-Stratified Case-Cross Study.
    Can Respir J. 2021;2021:3240785.
    PubMed     Abstract available


  23. GAN Q, Tang D, Yan Q, Chen J, et al
    Differential Expression Study of Lysine Crotonylation and Proteome for Chronic Obstructive Pulmonary Disease Combined with Type II Respiratory Failure.
    Can Respir J. 2021;2021:6652297.
    PubMed     Abstract available


  24. GOURGOULIANIS K, Ruggieri A, Del Vecchio A, Calisti F, et al
    Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Alpha Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice-The "AIOLOS" Study.
    Can Respir J. 2021;2021:6620585.
    PubMed     Abstract available


  25. DAVE C, Wharton S, Mukherjee R, Faqihi BM, et al
    Development and Relevance of Hypercapnia in COPD.
    Can Respir J. 2021;2021:6623093.
    PubMed     Abstract available


  26. YUN R, Bai Y, Lu Y, Wu X, et al
    How Breathing Exercises Influence on Respiratory Muscles and Quality of Life among Patients with COPD? A Systematic Review and Meta-Analysis.
    Can Respir J. 2021;2021:1904231.
    PubMed     Abstract available


  27. ZHAO K, Miles P, Jiang X, Zhou Q, et al
    BCG Vaccination in Early Childhood and Risk of Atopic Disease: A Systematic Review and Meta-Analysis.
    Can Respir J. 2021;2021:5434315.
    PubMed     Abstract available


  28. ALJAZEERI J, Sakkat A, Makhdami N, Almusally R, et al
    Blood Eosinophils and Pulmonary Rehabilitation in COPD.
    Can Respir J. 2021;2021:7449527.
    PubMed     Abstract available


  29. DING M, Han X, Bai L, Huang S, et al
    Impact of HACOR Score on Noninvasive Ventilation Failure in Non-COPD Patients with Acute-on-Chronic Respiratory Failure.
    Can Respir J. 2021;2021:9960667.
    PubMed     Abstract available


  30. YAO X, Wang X, Yuan J, Huang Z, et al
    Benefits Conferred by Peer-Support Nursing Intervention to Pulmonary Function and Quality of Life in Nonsmoking Patients with COPD.
    Can Respir J. 2021;2021:7450979.
    PubMed     Abstract available


  31. JIRANGE P, Vaishali K, Sinha MK, Bairapareddy KC, et al
    A Cross-Sectional Study on Balance Deficits and Gait Deviations in COPD Patients.
    Can Respir J. 2021;2021:6675088.
    PubMed     Abstract available


  32. FAQIHI BM, Parekh D, Trethewey SP, Morlet J, et al
    Ward-Based Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure Unrelated to Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2021;2021:4835536.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: